HARMONY IN DIVERSITY is the first study of combined neurotoxin and filler treatment in adults on glucagon-like peptide-1 (GLP ...
HARMONY IN DIVERSITY is the first study of combined neurotoxin and filler treatment in adults on glucagon-like peptide-1 (GLP-1) medications. In this Phase 4 cohort, participants reported statisticall ...
Law360 is on it, so you are, too. A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are ...
Patients interested in learning more about JUVÉDERM ® VOLUMA ® XC for temple hollowing are encouraged to enroll in AllÄ“, the Allergan Aesthetics loyalty rewards program. In serving more than seven ...
"The number one facial concern patients have is the eye area,12 so it is essential to consider treating the temples as part of a comprehensive treatment plan. With the approval and training-led launch ...
"In the months since approval, our focus has been on developing and implementing a robust training protocol designed to ensure providers are well versed in the science needed to inject the temple area ...
Recognized globally for its extensive line of hyaluronic acid dermal fillers, Juvederm, offered by Med Supply Solutions, stands at the forefront of cosmetic treatments designed to combat facial aging.
At 3 months, findings showed 80.4% of patients treated with Juvéderm Voluma XC achieved at least a 1-point improvement in moderate to severe temple hollowing. The Food and Drug Administration (FDA) ...
Allergan Aesthetics recently received approval from the U.S. Food and Drug Administration (FDA) for the injection of Juvederm Voluma XC in the temple region. This approval is specifically for the ...